Clinical Trials Directory

Trials / Sponsors / Tianjin SinoBiotech Ltd.

Tianjin SinoBiotech Ltd.

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
CompletedStudy on Single Administration and Dose Increment of Recombinant Human Serum Albumin/Erythrocyte Fusion Protei
Healthy Subjects
Phase 12018-12-03
CompletedRecombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patient
Chemotherapy-induced Neutropenia
Phase 22017-10-19
CompletedStudy of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B Patient
Hepatitis B Virus
Phase 1 / Phase 22017-06-13
CompletedStudy of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Chinese Healthy Volunteers
Healthy
Phase 12016-04-07
CompletedFusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients
Chemotherapy-induced Neutropenia, Cancer, Breast
Phase 12016-01-21
CompletedStudy of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein
Chemotherapy-induced Neutropenia
Phase 22014-12-16
CompletedSafety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia
Underdose (Unintentional), Cancer, Tumor
Phase 12012-10-01